The effects of chronic treatment with the 5-hydroxytryptamine uptake blocker zimelidine on central 5-hydroxytryptamine mechanisms. Evidence for the induction of a low affinity binding site for 5-hydroxytryptamine

Neurosci Lett. 1979 Aug;13(3):307-12. doi: 10.1016/0304-3940(79)91511-8.

Abstract

Male rats were treated with saline or the 5-hydroxytryptamine (5-HT) uptake inhibitor zimelidine (10 mumol/kg postoperatively) twice daily for a period of 14 days. The effects of this treatment on [5-3H]HT binding in the cerebral cortex and hypothalamus and on 5-HT synthesis were examined. Long-term treatment with zimelidine induced a low affinity site for 5-HT (Kd approximately 20 nM) in both areas and a reduced number of high affinity binding sites in the hypothalamus. Long-term zimelidine treatment did not attenuate the feed-back mediated inhibition of 5-HT synthesis. These findings suggest that chronic zimelidine treatment could result in a reduced activity at postsynaptic 5-HT receptor sites.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Allylamine / analogs & derivatives
  • Allylamine / pharmacology
  • Animals
  • Binding Sites / drug effects
  • Brain / metabolism*
  • Cerebral Cortex / metabolism
  • Hippocampus / metabolism
  • Hypothalamus / metabolism
  • Male
  • Nucleus Accumbens / metabolism
  • Olfactory Bulb / metabolism
  • Pyridines / pharmacology*
  • Rats
  • Receptors, Serotonin / drug effects*
  • Serotonin / biosynthesis
  • Serotonin / metabolism*
  • Serotonin Antagonists / pharmacology*

Substances

  • Pyridines
  • Receptors, Serotonin
  • Serotonin Antagonists
  • Serotonin
  • Allylamine